MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Surrogate endpoints"

  • 2019 International Congress

    Parkinson Kinetigraph – does it change the management of PD patients?

    F. Bergquist, A. Cvejtkovic, AC. Sjöström, S. Wallerstedt (Gothenburg, Sweden)

    Objective: This pragmatic randomized open trial evaluated if the information from a Parkinson Kinetigraph (PKG) recording changed the management of PD patients at a visit…
  • 2019 International Congress

    Motor assessments in HD clinical trials: Q-Motor versus the UHDRS-TMS – what did we learn from recent studies?

    R. Reilmann, R. Schubert, P. Barallon, P. Pracht, B. Habbel (Muenster, Germany)

    Objective: To review the performance of UHDRS-TMS and Q-Motor quantitative motor measures in recent placebo-controlled clinical trials. Background: The UHDRS-TMS has widely been used to…
  • 2019 International Congress

    Alignment of objective markers of speech with listener based judgements and disease severity in Friedreich ataxia

    A. Vogel, A. Tsanas, H. Reece, L. Corben, G. Tai, M. Delatycki (Melbourne, Australia)

    Objective: To identify a subset of acoustic markers of speech that objectively describe listener perceptions, disease severity and speech related quality of life in Friedreich…
  • 2019 International Congress

    Preliminary validation of a novel, comprehensive digital biomarker smartphone application to assess motor symptoms in de-novo diagnosed Parkinson patients

    F. Lipsmeier, K. Taylor, E. Volkova-Volkmar, R. Postuma, T. Kilchenmann, D. Wolf, Y. Zhang, W. Cheng, A. Scotland, J. Schjodt-Eriksen, F. Boess, D. Ness, C. Gossens, A. Post, M. Lindemann (Basel, Switzerland)

    Objective: To determine the reliability and validity of a novel, comprehensive digital biomarker remote monitoring approach to actively and passively measure motor symptom progression in…
  • 2018 International Congress

    A randomized, double-blind, placebo-controlled Phase II Efficacy and Safety Study of the PDE10A inhibitor PF-02545920 in Huntington Disease (AMARYLLIS)

    M. Delnomdedieu, Y. Tan, A. Ogde, Z. Berger, R. Reilmann (Cambridge, MA, USA)

    Objective: To assess efficacy on motor function, safety and tolerability of the phosphodiesterase-10A inhibitor PF-02545920 in Huntington disease (HD). Conclusion: PF-02545920 was generally safe and…
  • 2018 International Congress

    A comprehensive digital biomarker active testing and passive monitoring suite for the remote and frequent assessment of motor symptom progression in Parkinson’s disease

    K. Taylor, R. Postuma, F. Boess, F. Lipsmeier, T. Kilchenmann, L. Verselis, J. Soto, M. Koller, C. Gossens, A. Post, J. Sevigny, M. Lindemann (Basel, Switzerland)

    Objective: We present the development and design of a comprehensive digital biomarker smartphone application (app) for remote and frequent assessments of motor symptom severity and…
  • 2016 International Congress

    Evaluating Parkinsonian motor features via the routine use of consumer electronics – neuroQWERTY

    Á. Sánchez-Ferro, C.S. Mendoza, I. Butterworth, M. Matarazzo, P. Montero, R. Trincado, T. Arroyo Gallego, V. Puertas Martín, M.J. Catalán, J.A. Molina, F. Bermejo-Pareja, L. Giancardo (Móstoles, Spain)

    Objective: Our goal was to evaluate the validity and reproducibility of a novel metric, neuroQWERTY index (nQi), to characterize PD's motor component. Background: The motor…
  • « Previous Page
  • 1
  • 2

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley